PPIA and nasopharyngeal carcinoma: Liu et al. proposed that the detection of exosomal cyclophilin A (CYPA), a protein from immunophilin, helped distinguish NPC patients from healthy controls, which could greatly improve diagnostic precision when combined with the EBV antibody test [141].